Stefanie Schneider
About Stefanie Schneider
Stefanie Schneider is the Senior Director of Marketing at Beigene in Cambridge, Massachusetts, with over a decade of experience in strategic marketing roles within the pharmaceutical industry, particularly in oncology.
Current Position at Beigene
Stefanie Schneider serves as the Senior Director of Marketing at Beigene, based in Cambridge, Massachusetts, United States. In this role, she is responsible for leading marketing strategies and initiatives. One of her notable projects includes spearheading the marketing strategy for Zanubrutinib, focusing on markets outside of China. Her contributions are pivotal in driving Beigene's presence in the global pharmaceutical market.
Previous Role at Exelixis
Before joining Beigene, Stefanie worked at Exelixis where she held two prominent positions. She served as the Executive Director of GI Strategic Marketing and the Executive Director of Strategic Account Management. During her 11-month tenure in each role at Exelixis, she contributed to the strategic and marketing realms of gastrointestinal oncology products. Her work in Alameda, California, underscored her expertise in the oncology sector.
Experience at Portola Pharmaceuticals
Stefanie Schneider spent a year at Portola Pharmaceuticals as the Executive Director of Strategic Marketing from 2016 to 2017. Based in South San Francisco, California, she focused on developing and implementing marketing strategies for the company’s portfolio. Her role at Portola Pharmaceuticals further solidified her expertise in strategic marketing, especially within the pharmaceutical industry.
Tenure at Onyx Pharmaceuticals
Stefanie Schneider's extensive experience in strategic and product marketing is well-illustrated by her tenure at Onyx Pharmaceuticals. She held various roles over seven years, starting as the Senior Manager of Product Strategy from 2008 to 2010 and progressing to Associate Director of Global Product Strategy in 2010-2011. She then served as Director of US Marketing for the Proteasome Inhibition Franchise from 2011 to 2014 and subsequently as Senior Director of US Marketing for Kyprolis from 2014 to 2015. Her efforts at Onyx Pharmaceuticals were instrumental in the strategic marketing of oncology products, including the notable drug Kyprolis.
Strategic Marketing Expertise
With over a decade of experience in strategic marketing within the pharmaceutical industry, Stefanie Schneider has established herself as a seasoned professional in this field. Her extensive background in both US and global product strategy, particularly in oncology, highlights her ability to lead and execute successful marketing campaigns and strategies. Throughout her career, Stefanie has played significant roles in the marketing initiatives for various oncology products, influencing their impact and reach in the market.